7-valent pneumococcal conjugate vaccine (7vPnC)

BIOLOGICAL4 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer, Pfizer

Conditions

Healthy SubjectsPneumococcal Conjugate VaccinePneumococcal InfectionsVaccinesVaccines, Pneumococcal Conjugate Vaccine

Phase 1

Study Evaluating Pneumococcal Vaccine in Healthy Infants

CompletedNCT00205803

Wyeth is now a wholly owned subsidiary of PfizerHealthy Subjects, Pneumococcal Infections

Start: 2004-09-30End: 2007-05-31Updated: 2012-08-15

Phase 3

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil

CompletedNCT00676091

Wyeth is now a wholly owned subsidiary of PfizerVaccines, Pneumococcal Conjugate Vaccine

Start: 2008-04-30End: 2009-09-30Updated: 2011-08-08

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan

CompletedNCT00688870

Wyeth is now a wholly owned subsidiary of PfizerPneumococcal Conjugate Vaccine, Vaccines

Start: 2008-06-05End: 2010-01-13Updated: 2022-10-07

Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants

CompletedNCT01200368

PfizerHealthy Subjects

Start: 2010-09-24End: 2011-11-30Updated: 2018-12-19

Related Papers

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan.

2011-12-2213 citations